PTU - Polskie Towarzystwo Urologiczne
list of articles:

Article published in Urologia Polska 1999/52/2.


Kazimierz Krajka 1, Wojciech Lauer 1, Maciej Markuszewski 2, Stanisław Janicki 3
1 Katedra i Klinika Urologii AM w Gdańsku
Kierownik Kliniki: prof. dr hab. med. K. Krajka
2 Zakład Radiologii AM w Gdańsku
Kierownik Zakładu: lek. med. M. Markuszewski
3 Zakład Farmacji Stosowanej AM w Gdańsku
Kierownik Zakładu: prof. dr hab. farm. S. Janicki


urethra transitional cell carcinoma mitomycin C


A case of the patient with sigmoid bladder and recurrence of the urothelial
tumor in the urethra is presented. Young age and a kind of patienfs profession
made us create a method of intra-urethral chemotherapy with mitomycin C.
Gel consisting of Mitomicin C in the dose of 7.5/9.0 of Amipotrizoat in 75%
contretion and 6.0 ml Natrosol was administered by one of the canals of a three-
way Foley catheter with a hole made below the balloon. It was left in the urethra
for 30 minutes thariks to blocking by the baloon proximally and the Cunningham
clamp distally.


  1. [1] Coloby, P. J., Kakizoe, T., Tobishu, R. I., Sukamato, M. I.: Urethral invo-
  2. lvement in female bladder cancer patients: mapping of 47 consecutive cysto-ureth-
  3. rectomy specimens. J. Urol. 1994,152,1438-1442.
  4. [2] Hardeman, S. W., Soloway, M. S.: Urethral reccurrence following radical cy-
  5. stectomy. J. Urol. 1990,144, 666.
  6. [3] Herr, H. W., Cookson, M. S., Soloway, S. M.: Upper tract tumors in patients with
  7. primary bladder cancer followed for 15 years. J. Urol. 1996,156,1286-1287.
  8. [4] De Paepe, M. E., Andre, R., Matadevia, P.: Urethral involvement in pa-
  9. tients with bladder cancer. Cancer 1990, 5,1237-1241.
  10. [5] Patel, A., Fuchs, G.: New techni±ues for the administration of topical adjuyant
  11. therapy after endoscopic ablation of upper urinary tract transitional cell carcinoma.
  12. J. Urol. 1998,159, 71-75.
  13. [6] Rintala, E., Jauhiainen, R., Kaasinen, E., Nirmi, ML, Alfhtan, O.:Alter-
  14. nating Mitomycin C and BCG instillation prophylaxis for recurrent papillary su-
  15. perficial bladder cancer. J. Urol. 1996,156, 56-60.
  16. [7] Tobitsu, K. I., Tanaka, Y., Mizutani, T., Kakizoe, T.: Transitional cell car-
  17. cinoma of the urethra in men following cystectomy for bladder cancer: multivariate
  18. analysis for risk factor. J. Urol. 1991,146,1551.
  19. [8] Veyt, P. D. J., Debruyne, F. M. J., van der Meijden: Bacillus Calmette-
  20. Guerin in superficial bladder cancer: consensus and controversies. Eur. Urol. 1995,
  21. 27, 89-95.
  22. [9] Witjes, J. A., Caris, C. T. M., Mungan, N. A., Debruyne, F. M. I., Wi-
  23. tjes, W. P. J.: Results of a randomized phase III trial of se±uential intravesical thera-
  24. py with Mitomycin C and bacillus Calmette-Guerin versus Mitomycin C alone in
  25. patients with superficial bladder cancer. I. Urol. 1998,160,1668-1672.